	US 12,185,724 B2
	Abamectin soluble concentrate composition (SL)
Celine Meunier, Münchwilen (CH); Susan Waehrer-Eggs, Münchwilen (CH); Hildegard Schneider, Münchwilen (CH); Kerstin Garo, Münchwilen (CH); and Marion Janker, Münchwilen (CH)
Assigned to SYNGENTA CROP PROTECTION AG, Basel (CH)
Appl. No. 17/287,219
Filed by SYNGENTA PARTICIPATIONS AG, Basel (CH)
PCT Filed Oct. 22, 2019, PCT No. PCT/EP2019/078749 § 371(c)(1), (2) Date Apr. 21, 2021, PCT Pub. No. WO2020/083925, PCT Pub. Date Apr. 30, 2020.
Claims priority of application No. 18202400 (EP), filed on Oct. 24, 2018.
Prior Publication US 2021/0378243 A1, Dec. 9, 2021
Int. Cl. A01N 43/90 (2006.01); A01N 25/02 (2006.01)

CPC A01N 43/90 (2013.01) [A01N 25/02 (2013.01)]

13 Claims

1. A soluble concentrate composition comprising

(i) abamectin;

(ii) polyoxyethylene (20) sorbitan monolaurate;

(iii) polyoxyethylene (20) sorbitan monooleate;

wherein the weight ratio of polyoxyethylene (20) sorbitan monolaurate to polyoxyethylene (20) sorbitan monooleate is from 1:2.5 to 15:1.